Abstract
Malignant melanoma represents an important source of diagnostic error, litigation risk and poor litigation outcomes for dermatologists owing to its particularly lethal nature, ability to mimic benign lesions and tendency to affect relatively young individuals. This review provides an overview of the legal framework governing medical malpractice litigation in the USA, describes seven clinical scenarios that frequently serve as a basis for melanoma-related malpractice claims and discusses strategies for avoiding the diagnostic errors that commonly give rise to those scenarios.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
